person · Reporting owner

Nash Christine A

Disclosed activity across 1 company

Tapewire entity: 79754
SEC CIK: 0001554403

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Rallybio CorpRLYB · Entity 6838	Director	May 13, 2025	May 15, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Rallybio Corp

Report date May 13, 2025 · Filed May 15, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.30 · Expires 2035-05-13	Direct	28,500	Reported balance After 2025-05-13 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2025-05-13 · Grant · Acquired 28,500 · Balance 28,500 F1: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 13, 2026 or the date of the Company's 2026 Annual Meeting of Stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 13, 2026 or the date of the Company's 2026 Annual Meeting of Stockholders.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 13, 2025 Filed May 15, 2025 21:07 UTC	Rallybio Corp RLYB · Entity 6838	GrantOption (Right to Buy) · Derivative	28,500	$0.00 Strike: $0.30	$0.00	Disclosure SEC source: 0001739410-25-000084 · wk-form4_1747343247.xml · derivative · entry 1 Nash Christine A · CIK 0001554403 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-05-13 F1 · derivative.exercise_date: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 13, 2026 or the date of the Company's 2026 Annual Meeting of Stockholders. Read SEC document
May 15, 2024 Filed May 17, 2024 21:04 UTC	Rallybio Corp RLYB · Entity 6838	GrantOption (Right to Buy) · Derivative	16,500	$0.00 Strike: $1.91	$0.00	Disclosure SEC source: 0001739410-24-000089 · wk-form4_1715979821.xml · derivative · entry 1 Nash Christine A · CIK 0001554403 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2034-05-15 F1 · derivative.exercise_date: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 15, 2025 or the date of the Company's 2025 Annual Meeting of Stockholders. Read SEC document
May 17, 2023 Filed May 19, 2023 21:25 UTC	Rallybio Corp RLYB · Entity 6838	GrantOption (Right to Buy) · Derivative	15,490	$0.00 Strike: $5.64	$0.00	Disclosure SEC source: 0000899243-23-013406 · doc4.xml · derivative · entry 1 Nash Christine A · CIK 0001554403 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,490 Underlying: Common Stock · 15,490 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 17, 2024 or the date of the Company's 2024 Annual Meeting of Stockholders. Read SEC document
May 24, 2022 Filed May 27, 2022 00:09 UTC	Rallybio Corp RLYB · Entity 6838	GrantOption (Right to Buy) · Derivative	2,240	$0.00 Strike: $12.75	$0.00	Disclosure SEC source: 0000899243-22-019828 · doc4.xml · derivative · entry 1 Nash Christine A · CIK 0001554403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,240 Underlying: Common Stock · 2,240 shares Expires 2032-05-24 F1 · derivative.exercise_date: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 24, 2023 or the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document
April 04, 2022 Filed Apr 7, 2022 00:28 UTC	Rallybio Corp RLYB · Entity 6838	GrantOption (Right to Buy) · Derivative	26,880	$0.00 Strike: $8.22	$0.00	Disclosure SEC source: 0000899243-22-014169 · doc4.xml · derivative · entry 1 Nash Christine A · CIK 0001554403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,880 Underlying: Common Stock · 26,880 shares Expires 2032-04-04 F1 · derivative.exercise_date: The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in three equal annual installments beginning on April 4, 2023. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.